key: cord-0771092-h3ighqd4
authors: Lobiuc, A.; Dimian, M.; Puscaselu, R.; Sturdza, O.; Covasa, M.
title: Analysis of genome characteristics and transmission of SARS-CoV-2 strains in North-East of Romania during the first COVID-19 outbreak
date: 2020-12-24
journal: nan
DOI: 10.1101/2020.12.22.20248741
sha: 89bd7ede997bb3c2a10c149085bf9c136a217b6e
doc_id: 771092
cord_uid: h3ighqd4

Romania officially declared its first SARS-CoV-2 case on February 26, 2020. The first and largest COVID-19 outbreak in Romania was recorded in Suceava, N/E region of the country, and originated at the Suceava regional county hospital. Following sheltering-in-place measures, infection rates decreased, only to rise again after relaxation of measures. This study describes the incursion of SARS-CoV-2 in Suceava and other parts of Romania and analyzes the mutations and their association with clinical manifestation of the disease during the period of COVID-19 outbreak. Phylogenetic analysis indicated multiple sites of origin for SARS-CoV-2 strains in Suceava, specifically from Spain, Italy and Russia, but also other strains related to those from Czech Republic, Belgium and France. Most Suceava samples contained mutations common to European lineages, such as A20268G, however aproximately 10% of samples were missing such mutations, indicating a possible different origin. While overall genome regions ORF1ab, S and ORF7 were subject to most mutations, several recurring mutations such as C27707T were identified, and these were mainly present in severe forms of the disease. Non-synonymous mutations, such as C3225A (Thr987Asn in NSP3a domain), associated with changes in a protein responsible for decreasing viral tethering in human host were also present. Patients with diabetes and hypertension exhibited eight and three time,s respectively, higher odds ratios of acquiring severe forms of the disease and these were mainly related to C27707T mutation. These results will aid in tracing virus movement throughout Romania and identification of infectivity, virulence and pathogenicity.

The first whole genome sequence was published on January 5, 2020, and since then thousands of 66 genomes have been sequenced and deposited in the Global Initiative on Sharing All Influenza Data (GISAID) 67 database [9] . This data revealed that it shares approximately 79.6% similarity with SARS-CoV at the 68 nucleotide level, and varies between the different genes. SARS-CoV-2 contains a linear single-stranded 69 positive-sense RNA as genetic material that encodes for the spike (S), envelop (E), membrane (M), and 70 nucleocapsid (N) proteins [10] . The S glycoprotein is a transmembrane protein found on the viral outer 71 membrane. S protein forms homotrimers that protrude the viral surface and facilitate binding of viral 72 envelope to host cells by interacting with angiotensin-converting enzyme 2 (ACE2) receptors expressed on 73 the lower respiratory tract cells. 74 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 24, 2020. ; https://doi.org/10.1101/2020.12.22.20248741 doi: medRxiv preprint

Since the introduction of SARS-CoV-2 in territories outside Asia, continous efforts have been made 75 to map strains and lineages. With time, the viral spread brought about mutations specific to geographical 76 regions, thus making possible to track the virus movement within communities and across the globe. One of 77 the most well known mutations is in position 23404, changing an aspartate for a glycine at residue 614 in 78 Spike protein and, presumably, offering an advantage in viral replication [11] . This mutation appeared in 79 January 2020 in China, and after a week in Europe and, was later observed in Africa and Americas [12] , giving 80 birth to the "G" clade, now characteristic to Europe March 3, 2020, pacient number 6 was diagnosed with COVID-19 and hospitalized at the Regional County 88

Hospital of Suceava, North East of Romania. This led to a rapid contamination of medical personnel and the 89 Regional Hospital of Suceava became the largest outbreak of COVID-19 in the country that still leads in the 90 number of confirmed cases and deaths nationwide. Suceava Regional Hospital serves more than 600,000 91 people and is the largest hospital in the North-East region of the country. On March 26, a SARS-CoV-2 92 diagnostic laboratory (RT-PCR based) was set up within the hospital that allowed identification of pacients 93 with SARS-CoV-2 infection. Suceava county has one of the largest migrant population working in EU countries 94 who begun returning to Romania once COVID-19 spread accross Europe. The initial epidemiological analysis 95 on a small sample of patients from Bucharest (capital of Romania) and several counties collected between 96 February and March 2020 indicated that Romanian migrants from Italy were the main source of virus spread 97 [16] . In order to understand the source and transmission of the virus of this largest outbreak, we perfomed 98 sequencing and phylogenetic analyses of viral samples from patients with confirmed SARS-CoV-2 infection 99 from Suceava county. We then compared the data with those reported from other regions of the country as 100 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 24, 2020. ; https://doi.org/10.1101/2020.12.22.20248741 doi: medRxiv preprint 6 well as several European countries accessed from GISAID data. Finally, we examined whether specific variants 101 in SARS-CoV-2 proteins were associated with patients' clinical parameters and disease outcomes. 102

A total of 62 samples were selected, based on quality checks, comprising 39 samples from males and 105 23 from females. When compared with Wuhan reference Genome, GISAID accesion ID Nc_045512.2, a total 106 of 190 modifications were recorded and distributed across 8 genome regions. With ORF1ab being the largest 107 SARS-CoV-2 gene (approximately 24 kb), corresponding to a polyprotein made up of 16 non-structural 108 proteins (NSP1-16), over 66% of all mutations were recorded in this region. This was followed by the spike 109 (S) and nucleocapsid (N) protein coding genes while other genes, such as ORF3a, ORF7a or envelope (E) 110

represented less than 5% of all mutations (Fig. 1) . 111 Of the mutations recorded, the highest proportion belongs to transitions, accounting for over 76% 119 of them, while only 23.7 % are transversions. Specifically, C to T (U) transitions make up almost 50% of all 120 SNPs recorded, followed by G to T (U) transversions (17%), A to G (11%) and T(U) to C (10%) transitions (Fig.  121 3). Overall, the transitions:transversions ratio is 3.2:1, with a value >1 for most genes. 122 arrows indicate how many times that particular mutation was recorded; T is replaced by U in the 125 original, RNA sequence; blue, transitions; green, transversions. 126 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 24, 2020. ; https://doi.org/10.1101/2020.12.22.20248741 doi: medRxiv preprint When considering aminoacid sequences, modifications at most frequent positions were of 127 synonymous type, however, a large proportion induced aminoacid alterations, such as those at positions 314 128 in ORF7a and 1841 in S genes (Table 1 ). At the entire genome level, for certain ORFs, the number of non-129 synonymous mutations was higher than that of synonymous ones (Fig. 4) . 130 

145 Suceava outbreak was the first and the largest in the country. The evolution of SARS-CoV-2 infection 146 was chronologically different in Suceava, compared to other regions of the country, peaking in March then 147 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 24, 2020. ; https://doi.org/10.1101/2020.12.22.20248741 doi: medRxiv preprint decreasing sharply while in the rest of the country, particularly in the N-E region there was a gradual increase 148 in case prevalence (Fig. 5) . 149

September 2020. 151

To examine the phylogenetic distribution of SARS-CoV-2 from Suceava county, we first compared 152 these samples (n=62) with those from other regions of Romania (n=50). All sequences were submitted to 153 GISAID (https://www.gisaid.org/) with accession numbers listed in S1 Table. The Then, we compared phylogenetic distribution of Romanian strains with representative samples from 161 European viral genomes. To do this, a maximum likelihood tree was constructed, using bootstrapped RaxML 162 ( Fig. 7) . Overall, Romanian strains formed several clusters with strains from specific European regions such 163 as Spain, Russia, Italy, Turkey, England and Austria (Fig. 7) . 164 were mainly grouped with samples from France, Spain, Russia, Scotland and Belgium. A second cluster 173 consisted of 6 Bucharest strains sampled between 12 and 18 April, 2020 that tracked together exclusively 174 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 24, 2020. ; https://doi.org/10.1101/2020.12.22.20248741 doi: medRxiv preprint with a set of strains from Italy (24 March -9 April, 2020). A third cluster, also comprising strains from the 175 southern part of the country (Buzau) collected in June, grouped with strains from Austria, England and Czech 176

Republic. Another strain from Suceava (April, 2020) was related to samples from the Czech Republic (March), 177 while a sample from Buzau (June) was related to samples from England (May). 178

The relationship between strains was also obtained when inferring phylogenies using Nextstrain 179 application, which is based on more than 30.000 sequences from the GISAID database (Fig. 8) . 180 perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 24, 2020. ; https://doi.org/10.1101/2020.12.22.20248741 doi: medRxiv preprint 11 20 days). In order to identify factors that significantly influenced disease severity and clinical outcome we 202 examined viral copy number, number of mutations, number of hospitalized days, age, sex and certain 203 comorbidities, such as diabetes, obesity and hypertension. Among continuous variables, only the number of 204 hospitalized days showed significant differences between asymptomatic and mild status patients (Table 3) . 205

Although the average number of hospitalized days was highest in mildly diseased patients, the hospitalization 206 days ranged from 4 to 22 days for asymptomatics, 7 to 39 days for mild status and 9 to 34 days for severe 207 status. Sex was not significantly correlated with the severity of disease (Pearson's rho = 0.17). 208 When examining the effect of comorbidities on clinical outcome, the percentages of hypertensive, 211 diabetic and obese patients were higher among mild and severe forms (Table 4 ). When comparing 212 asymptomatic patients with mild and severe forms, logistic regression analysis revealed a significant 213 association with hypertension and diabetes with an odds ratio (risk ratio) of 8.47 (p=0.008) and 3.28 214 (p=0.037) for hypertension and diabetes, respectively. These patients were eight (hypertension) and three 215 (diabetes) times more likely to develop a severe form of the disease. 216 perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted December 24, 2020. ; https://doi.org/10.1101/2020.12.22.20248741 doi: medRxiv preprint None of the above factors (viral copy number, days of hospitalisation, comorbidities) were 219 significantly associated with the number of deaths possibly due to the low numbers of such patients (n=7). It 220 should be noted however, that out of the 7 deceased patients, 2 had hypertension, 1 was diabetic and 3 were 221 obese. 222

To investigate possible effects of viral mutations on disease outcome we screened for non-223 synonymous reccuring mutations, in patients with severe clinical forms and those deceased. We found that 224 structural data is only available for the 16-82 residues range, protein modelling was performed ab initio, 234 independently, using Phyre2 (17) and I-TASSER (18), for both mutated and wild proteins (Fig. 11) . 235

Superimposing structures yielded a RMSD value of 2.33 Å for Phyre2 predicted structures and 2.29 Å for I-236 TASSER ones and, correspondingly, a TM score of 0.85 for both cases. 237 perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 24, 2020. ; https://doi.org/10.1101/2020.12.22.20248741 doi: medRxiv preprint were ab initio modeled. The two models, for mutated and original sequence, recorded a RMSD of 3.81 Å and 246 a TM-score of 0.60 (Fig. 12) . 247

The sequence and phylogenetic analyses of SARS-CoV-2 strains showed that Romanian samples 249 appear heterogenous in the quality and quantity of mutations and supports the idea of multiple sources of 250 virus introduction in the country. When integrating sequencing data with clinical parameters of patients, our 251 results identified specific viral mutations that were associated with the degree of disease severity and 252 patients' comorbidities. 253 Poland. Therefore, It appears that B1.1. strains originated in Romania around late March to early April from 295

England, Austria and Czech Republic. Otherwise, Romanian samples belonging to B.1.5 lineage were mixed, 296 mainly with samples from Russia, Italy, Spain and Austria. These results support a multiple source of virus 297 introduction in the country with one route being Spain, Italy and Turkey, the second England, Austria and 298

Czech Republic and a third from East Russia and beyond. Clearly, strains from Suceava grouped together, 299 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 24, 2020. ; https://doi.org/10.1101/2020.12.22.20248741 doi: medRxiv preprint perhaps because the city and adjacent regions were under mobility restrictions, while a wider distribution of 300 the virus was observed across Romania, especially after restrictions were removed. 301 318 Among mutations in SARS-CoV-2, some result in protein structure and properties changes. One such 319 mutation is D614G, which, over the course of one month, became prevalent in viral strains worldwide. 320

Although D614G mutation was associated with lower Ct values in RT-PCR analyses [11], our samples recorded 321 a very large range of Cts, between 17 and 36, suggesting that several factors, probably both virus and host 322 related, influence viral titres.This mutation is associated with less shedding of S1 subdomain of the S protein, 323 increased viral stability and transmission, although not necessarily with increased disease severity [33] , while 324 other studies associated D614G and P4715L with increased mortality. 325 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 24, 2020. ; https://doi.org/10.1101/2020.12.22.20248741 doi: medRxiv preprint Another nonsynonymous recurrent mutation in a large number of our samples was the replacement 326 of alanine with valine, in position 105. Our model of protein modification showed that this mutation has a 327 high probability to modify an alfa-helix stretch into a beta-sheet conformer since valine is a hydrophobic 328 amino acid known to be one of the best β-sheet former [34] . Therefore, the replacement of alanine 105 329 residue to valine favors β-sheet`s secondary structure. The ORF7a region in genomes of coronaviruses 330 encodes a 5.5 kDa protein, with a putative role in enhancing virulence in SARS-CoV. In SARS-CoV-1, the 122 331 residues long protein (accessory protein 7a) an integral membrane protein is, localized in the Golgi 332 compartments, probably in the budding regions [35] . It was shown to be involved in cell apoptosis, through 333 caspase-dependent pathway, cell protein synthesis inhibition, cell cycle progression blockage and 334 proinflammatory action, thus altering the host cellular environment [36, 37] . Interestingly, this protein is 335 known to interact with a viral release inhibitor, bone marrow stromal antigen 2 (BST-2 or CD317 or tetherin). perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 24, 2020. ; https://doi.org/10.1101/2020.12.22.20248741 doi: medRxiv preprint Glu-rich region were observed in the transcription factor Mytl1l known to be involved in the general function 353 of binding nucleic acids. NSP3a can be classified as a "low complexity region", found in many viruses, including 354

Coronaviridae. Such regions are considered to be highly immunogenic and, importantly, they share high 355 simmilarity with human epitopes, thus making them a risk for antiviral drug or testing development [ of SARS-CoV-2 positive samples were selected for analysis. RNA (100 ng) was reverse transcribed using 378 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 24, 2020. ; https://doi.org/10.1101/2020.12.22.20248741 doi: medRxiv preprint SuperScript™ VILO™ cDNA Synthesis Kit (Invitrogen, USA), according to product protocol. Targets for 379 sequencing were obtained based on Ion AmpliSeq™ SARS-CoV-2 Panel (ThermoFisher, USA). Library 380 preparation was made using Ion AmpliSeq™ Library Kit Plus (ThermoFisher, USA), then libraries were loaded 381 on sequencing chips using Ion Chef equipment. Next generation sequencing was performed on Ion S5 Gene 382 Studio, using Ion Torrent 540 chips. 383

Sequence processing and data availability 384 Sequences were assembled using the Iterative Refinement Meta Assembler (IRMA), after which 385 variants were called with Torrent VariantCaller plugin, referenced to the Wuhan SARS-CoV-2 sequence and 386 annotated using SnpEff plugin. Sequences were uploaded in GISAID database on 2020-07-11 and 2020-07-387

Phylogenetic analysis 389 To assess phylogenetic placement of Romanian strains that included those from Suceava and other 390 regions, a GISAID survey was performed, selecting European, and UK strains, under the "high coverage", "low 391 coverage excluded", "complete" criteria. All 112 Romanian samples present in GISAID at the time of writing 392 this article were included, together with another 1016 European samples. After removing duplicate 393 sequences and those with long stretches of "nnn", a total of 859 strains were considered for analyses. Prior 394 to phylogenetic analyses, all samples were aligned using MAFFT algorithm, then trimmed at ends, to remove 395 unnecessary artifacts caused by sequencing in those areas. 396

Phylogenetic analysis of our sequenced samples and selected European ones was performed based 397 on maximum likelihood algorithms, using RaxML-HPC2 workflow on CIPRES platform, phylo.org [46] . Set 398 parameters were GTR Gamma model and a bootstrap value of 100. The resulting tree was loaded, visualized 399 and annotated in ITOL platform, itol.embl.de [47] . Bayesian time dated phylogenetic analysis of the data set 400 was performed using BEAST 2.6.3, with Beagle library enabled. A HKY + Γ model of nucleotide substitution 401 and a strict clock were assigned, using a coalescent exponential population model. A continuous-time Markov 402 chain was employed, posterior distributions of parameters were estimated by sampling every 5000 steps 403 over a total of 50 million MCMC steps. Each analysis was run in duplicate to check for convergence, and the 404 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 24, 2020. ; https://doi.org/10.1101/2020.12.22.20248741 doi: medRxiv preprint first 10% of samples were discarded as burn-in. Sampling was considered effective when a minimum of 200 405 Estimated Sample Size was reached. 406

407 Differences between patient groups (asymptomatic, mild, severe) were assessed using ANOVA, 408 followed by a Duncan post-hoc test, while correlations were evaluated by Spearman's coefficient. Ordinal or 409 binary logistic regression was applied for severity categories, while binary logistic regression was applied 410 when various factors were assessed in relation with patient's status. All statistical analyses were conducted 411 using Minitab 19.2020.1 (Minitab LLC). 412 

Novel human coronavirus (SARS-CoV-2): A lesson from animal coronaviruses

CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-422 2): a global pandemic and treatment strategies

Overview of the 424 current promising approaches for the development of an effective severe acute respiratory syndrome 425 coronavirus 2 (SARS-CoV-2) vaccine

SARS-coV-2: An emerging coronavirus that causes a global threat

Cytokine storm induced by SARS-CoV-2

Genomic characterization of a novel SARS-CoV-2

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral 434 structure and host response

Potential adjuvants for the development of a SARS-CoV-2 vaccine based on 438 experimental results from similar coronaviruses

CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Genomic 444 diversity and hotspot mutations in 30,983 SARS-CoV-2 genomes: moving toward a universal vaccine 445 for the "confined virus

Evolutionary 447 and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide

Streinu-Cercel A. Sars-cov-2 in Romania -situation update and containment strategies

Early spread of COVID-19 in Romania: imported cases from Italy and 454 human-to-human transmission networks

The Phyre2 web portal for protein modeling, 456 prediction and analysis

All rights reserved. No reuse allowed without permission. perpetuity

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted

I-TASSER server for protein 3D structure prediction

Variant analysis of SARS-cov-2 genomes

Geographic and Genomic Distribution of SARS-CoV-2 Mutations

Mutation landscape 462 of SARS-CoV-2 reveals three mutually exclusive clusters of leading and trailing single nucleotide 463 substitutions

Genotyping coronavirus SARS-CoV-2: methods and implications

Genetic cluster analysis of SARS-CoV-2 and the identification of 467 those responsible for the major outbreaks in various countries

Genetic spectrum and distinct evolution patterns of SARS-470

SARS-CoV-2 disease severity and diabetes: why the connection and what is 472 to be done?

The Impact of SARS-CoV-2 on the Most 476

SARS-CoV-2 and diabetes: New challenges 479 for the disease

Binding of SARS coronavirus to its receptor damages islets and causes 481 acute diabetes

ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, 483 hypertension, multi-organ failure, and COVID-19 disease outcome

All rights reserved. No reuse allowed without permission. perpetuity

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted

Age-specific SARS-CoV-2 486 infection fatality ratio and associated risk factors

Age could be driving 489 variable SARS-CoV-2 epidemic trajectories worldwide. medRxiv

Caillet-Boudin ML, Lemay P, Boulanger P. Functional and structural effects of an Ala to Val mutation 493 in the adenovirus serotype 2 fibre

SARS-coronavirus orf7a accessory protein

SARS coronavirus 7a protein blocks cell cycle 497 progression at G0/G1 phase via the cyclin D3/pRb pathway

SARS coronavirus accessory gene expression and function

Critical role for bone marrow stromal antigen 2 in 501 acute Chikungunya virus infection

Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering 504 through a Novel Mechanism of Glycosylation Interference

Hypothetical targets and plausible drugs of coronavirus infection 506 caused by SARS-CoV-2 [Internet]. Transboundary and Emerging Diseases

ORF7a identified from sentinel surveillance in 1. medRxiv. 2020;2020.04.17

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 24, 2020. ; https://doi.org/10.1101/2020.12.22.20248741 doi: medRxiv preprint All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 24, 2020. Table. Accession number of Romanian/Suceava SARS-CoV-2 genome sequences submitted to GISAID 528 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted December 24, 2020. ; https://doi.org/10.1101/2020.12.22.20248741 doi: medRxiv preprint